Related Experiment Videos
Association between HbA1c and cardiovascular disease mortality in older Hong Kong Chinese with diabetes
1Department of Community Medicine and School of Public Health, University of Hong Kong, Hong Kong, China.
Insights
High HbA1c levels in older adults with diabetes are linked to increased mortality from all causes, cardiovascular disease, coronary heart disease, and stroke. Further research is needed to understand if low HbA1c also impacts mortality in this population.
Area of Science:
- Gerontology
- Endocrinology
- Epidemiology
Background:
- Diabetes mellitus is a chronic condition affecting millions globally, particularly older adults.
- Glycemic control, measured by HbA1c, is crucial for managing diabetes complications.
- Understanding the relationship between HbA1c levels and mortality risk in elderly populations is vital for public health strategies.
Purpose of the Study:
- To investigate the association between baseline HbA1c levels and mortality from all causes, cardiovascular disease, coronary heart disease, and stroke.
- To determine if different HbA1c ranges predict varying mortality risks in older Chinese adults with diabetes.
Main Methods:
- A cohort of 2137 Chinese adults aged 65+ with diagnosed diabetes was followed for up to 11 years.
- HbA1c levels were measured between 1998-2000, with data on lifestyle and medical history collected.
- Cox proportional hazards models were used to calculate adjusted hazard ratios and 95% confidence intervals for mortality outcomes.
Main Results:
- Higher HbA1c levels (≥69 mmol/mol) were associated with increased risk of cardiovascular disease and stroke mortality compared to HbA1c of 58-68 mmol/mol.
- Elevated HbA1c also increased all-cause and coronary heart disease mortality risk compared to HbA1c ≤48 mmol/mol.
- A U-shaped association was observed for stroke mortality, with both very low and high HbA1c levels potentially increasing risk.
Conclusions:
- Elevated HbA1c is a significant predictor of increased all-cause, cardiovascular, coronary heart disease, and stroke mortality in older adults with diabetes.
- The potential for low HbA1c levels to also increase mortality in this demographic warrants further investigation.
Objective:
To examine the association between baseline HbA(1c) level and mortality attributable to all-cause, cardiovascular disease, coronary heart disease and stroke.
Methods:
A total of 2137 Chinese aged 65 years or above attending the Elderly Health Service, Department of Health, Hong Kong, with diagnosed diabetes had HbA(1c) measured during 1998 to 2000 and were followed up to 2009. Information on socio-economic position, lifestyle factors and disease history was collected. Hazard ratios and 95% confidence intervals with adjustment for potential confounders were calculated using Cox's proportional hazards models.
Results:
After an average of 7.9 years of follow-up, 540 participants had died. After adjusting for potential confounders, higher HbA(1c) (≥ 69 mmol/mol, 8.5%) increased the risk of cardiovascular disease (hazard ratio 2.11;95% CI 1.37-3.25) and stroke mortality (hazard ratio 2.43; 95% CI 1.06-5.55) compared with HbA(1c) of 58-68 mmol/mol (7.5-8.4%), and increased the risk of all-cause (hazard ratio 1.41; 95% CI 1.06-1.86) and coronary heart disease mortality (hazard ratio 2.44; 95% CI 1.11-5.37) compared with HbA(1c) of 48 mmol/mol (6.5%) or less. Analysis of HbA(1c) as a continuous variable showed that every XX mmol/mol (1%) increase in HbA(1c) decreased stroke mortality risk by 51% in those with HbA(1c) level less than 48 mmol/mol (6.5%) and increased stroke mortality risk by 30% in those with an HbA(1c) level of 48 mmol/mol (6.5%) or higher, suggesting a U-shaped association between HbA(1c) and stroke mortality.
Conclusion:
High HbA(1c) predicted excess risk of all-cause, cardiovascular disease, coronary heart disease and stroke mortality. The question of whether low HbA(1c) increases mortality in older patients with diabetes needs further investigation.
Related Concept Videos
Coronary Artery Disease I: Introduction
Hyperglycemia
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes: Symptoms, Diagnosis, and Complications
Diabetic Retinopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy